Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $3.12M | -2,323.90% | -87.00% | 414.59% | -230.60% | -3.89 | 0.75 | N/A | N/A | N/A | ||
| FBLG | FIBROBIOLOGICS INC | $12.97M | -1,219.20% | -146.50% | -914.69% | -666.90% | 68.95 | 0.78 | N/A | N/A | N/A | ||
| PSTV | PLUS THERAPEUTICS INC | $38.89M | N/A | -172.50% | -334.59% | 276.00% | 2.69 | 1.29 | 100.00% | -391.30% | -321.61% | ||
| RCKT | ROCKET PHARMACEUTICALS INC | $373.37M | -62.40% | -53.90% | -70.95% | -83.00% | 0.17 | 7.30 | N/A | N/A | N/A | ||
| NRXP | NRX PHARMACEUTICALS INC | $49.87M | N/A | -489.90% | 148.69% | 172.10% | -1.58 | 0.29 | 59.90% | -15,727.70% | -15,727.69% | ||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $7.10M | -102.00% | -72.10% | -108.89% | -197.80% | 0.51 | 3.66 | 63.00% | -491.30% | -504.08% | ||
| NAKA | NAKAMOTO INC | $111.28M | -73.80% | -51.10% | -18.93% | -54.80% | 0.45 | 0.13 | 98.80% | -4,569.50% | -4,568.60% | ||
| OSTX | OS THERAPIES INC | $41.20M | N/A | -278.90% | -380.14% | 550.60% | 1.17 | 0.56 | N/A | N/A | N/A | ||
| SGMO | SANGAMO THERAPEUTICS INC | $122.15M | -814.00% | -116.50% | -283.90% | -311.60% | 13.20 | 0.88 | 100.00% | -331.30% | -332.63% | ||
| SLE | SUPER LEAGUE ENTERPRISE INC | $3.37M | N/A | -164.10% | 1,430.62% | 529.20% | -5.34 | 0.47 | 39.60% | -137.10% | -112.29% | ||
| TLRY | TILRAY BRANDS INC | $883.12M | -114.80% | -87.50% | -120.17% | -196.50% | 0.35 | 2.81 | 28.00% | -252.20% | -263.98% | ||
| PDSB | PDS BIOTECHNOLOGY CORP | $32.87M | -209.00% | -83.30% | -150.77% | -287.10% | 2.67 | 2.09 | N/A | N/A | N/A | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $29.34M | -20,541.50% | -187.50% | -494.36% | 222.10% | 2.15 | 1.39 | N/A | N/A | N/A | ||
| GUTS | FRACTYL HEALTH INC | $57.70M | -3,645.20% | -133.00% | -127.83% | -149.70% | -36.96 | 4.27 | 100.00% | -4,073,233.30% | -4,073,233.33% | ||
| ACET | ADICET BIO INC | $67.62M | -77.90% | -64.30% | -94.62% | -84.00% | 0.29 | 5.62 | N/A | N/A | N/A | ||
| ENLV | ENLIVEX THERAPEUTICS LTD | $27.21M | -62.90% | -53.30% | -82.65% | -29,748.70% | 0.20 | 6.43 | N/A | N/A | N/A | ||
| IFRX | INFLARX NV | $59.55M | -68.50% | -53.20% | -86.90% | -104.20% | 0.44 | 3.33 | -8,223.10% | -63,818.90% | -63,757.59% | ||
| SNTI | SENTI BIOSCIENCES INC | $24.19M | -197.70% | -63.10% | -117.03% | -75.10% | 5.49 | 1.51 | N/A | N/A | N/A | ||
| TVRD | TVARDI THERAPEUTICS INC | $33.77M | -115.90% | -33.70% | -31.65% | -30.90% | 0.40 | 3.48 | 100.00% | -346.50% | -220.05% | ||
| VNRX | VOLITIONRX LTD | $26.40M | N/A | -276.70% | 450.89% | -404.40% | -1.22 | 0.12 | 100.00% | -1,554.30% | -1,523.31% | ||
| HUMA | HUMACYTE INC | $202.25M | N/A | -27.90% | -39.90% | -24.80% | -20.26 | 1.62 | 60.50% | -2,353.20% | -1,674.35% | ||
| PALI | PALISADE BIO INC | $251.82M | -240.70% | -137.30% | -320.89% | 577.10% | 1.17 | 1.96 | N/A | N/A | N/A | ||
| ACRV | ACRIVON THERAPEUTICS INC | $50.17M | -53.70% | -48.30% | -62.69% | -69.00% | 0.13 | 8.75 | N/A | N/A | N/A | ||
| TNYA | TENAYA THERAPEUTICS INC | $105.07M | -95.50% | -76.80% | -102.71% | -122.30% | 0.27 | 4.64 | N/A | N/A | N/A | ||
| CTSO | CYTOSORBENTS CORP | $40.70M | -91.50% | -22.10% | -28.58% | -19.00% | 4.07 | 2.11 | 77.00% | -30.80% | -29.65% | ||
| INTZ | INTRUSION INC | $17.93M | -79.70% | -55.00% | -71.82% | -99.70% | 0.39 | 3.11 | 75.90% | -112.40% | -110.70% | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $157.97M | N/A | -129.00% | 273.69% | -132.60% | -2.81 | 0.26 | 100.00% | -2,359.60% | -2,053.83% | ||
| CAN | CANAAN INC | $300.33M | -60.70% | -34.60% | -43.56% | -62.00% | 0.38 | 3.31 | 7.80% | -39.70% | -38.80% | ||
| APRE | APREA THERAPEUTICS INC | $4.59M | -88.10% | -68.80% | -118.96% | 597.10% | 0.31 | 5.20 | 100.00% | -2,670.60% | -2,836.07% | ||
| MREO | MEREO BIOPHARMA GROUP PLC | $66.99M | -75.00% | -63.70% | -90.19% | 3,290.60% | 0.15 | 8.71 | 73.60% | -8,314.60% | -8,583.60% | ||
| CABA | CABALETTA BIO INC | $301.31M | -107.10% | -82.90% | -108.54% | -298.40% | 0.36 | 3.60 | N/A | N/A | N/A | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $31.99M | -144.40% | -71.70% | -109.10% | -184.00% | 1.69 | 3.87 | N/A | N/A | N/A | ||
| HELP | CYBIN INC | $354.25M | -65.60% | -55.90% | -48.03% | -428.20% | 0.06 | 13.78 | N/A | N/A | N/A | ||
| TCRX | TSCAN THERAPEUTICS INC | $57.88M | -73.90% | -45.10% | -59.97% | -67.10% | 0.82 | 6.44 | 100.00% | -1,693.00% | -1,659.11% | ||
| LUNG | PULMONX CORP | $58.57M | -77.60% | -37.90% | -45.97% | -50.10% | 1.30 | 4.86 | 73.30% | -61.90% | -57.87% | ||
| CRBU | CARIBOU BIOSCIENCES INC | $151.42M | -80.80% | -62.70% | -94.14% | -69.20% | 0.38 | 5.54 | 100.00% | -1,690.40% | -1,690.54% | ||
| AUTL | AUTOLUS THERAPEUTICS PLC | $415.18M | -63.80% | -30.90% | -40.97% | -28.80% | 1.49 | 6.19 | -61.20% | -439.70% | -463.91% | ||
| DARE | DARE BIOSCIENCE INC | $23.58M | N/A | -82.70% | -183.21% | 165.90% | 9.76 | 1.18 | -44.70% | 30,568.80% | 30,568.80% | ||
| DEFT | DEFI TECHNOLOGIES INC | $271.75M | N/A | N/A | N/A | N/A | 9.32 | 0.88 | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.